Back to Search Start Over

Obesity, obesity-related metabolic conditions, and risk of thyroid cancer in women: results from a prospective cohort study (Sister Study).

Authors :
Pasqual E
O'Brien K
Rinaldi S
Sandler DP
Kitahara CM
Source :
Lancet regional health. Americas [Lancet Reg Health Am] 2023 Jun 14; Vol. 23, pp. 100537. Date of Electronic Publication: 2023 Jun 14 (Print Publication: 2023).
Publication Year :
2023

Abstract

Background: Thyroid cancer incidence has increased worldwide. Obesity trends may play a role, but the underlying biological pathways are not well-characterized. Therefore, we examined associations of excess adiposity and obesity-related metabolic conditions with thyroid cancer incidence.<br />Methods: From the Sister Study, a cohort of sisters of women with breast cancer, we included 47,739 women who were cancer-free at baseline (2003-2009). Height, weight, waist and hip circumference, and blood pressure were measured at baseline and medical history was self-reported. Cox proportional hazards regression models were adjusted for age (time scale), race/ethnicity, smoking, baseline history of benign thyroid disease, and frequency of routine healthcare visits.<br />Findings: During follow-up (median = 12.5; max = 15.9 years), 259 women reported incident thyroid cancer. Body mass index (BMI) (hazard ratio [HR] <subscript>per-5 kg/m</subscript> <superscript>2</superscript>  = 1.25, 95% CI = 1.14-1.37), waist circumference (HR <subscript>per-5 cm increase</subscript>  = 1.11, 95% CI = 1.06-1.15), and waist-to-hip ratio (HR  <subscript>≥0.85-versus-<0.85</subscript>  = 1.49, 95% CI = 1.14-1.94) were positively associated with thyroid cancer incidence, as were metabolic syndrome (HR = 1.67, 95% CI = 1.24-2.25), dyslipidemia (HR = 1.46, 95% CI = 1.13-1.90), borderline diabetes (HR = 2.06, 95% CI = 1.15-3.69), hypertension (HR = 1.49, 95% CI = 1.12-1.96), and polycystic ovary syndrome (PCOS, HR = 2.10, 95% CI = 1.20-3.67). These associations were attenuated with additional BMI adjustment, although dyslipidemia (HR = 1.35, 95% CI = 1.04-1.75) and PCOS (HR = 1.86, 95% CI = 1.06-3.28) remained associated with thyroid cancer incidence. Hypothyroidism was not associated with thyroid cancer.<br />Interpretation: In this cohort of sisters of women diagnosed with breast cancer, excess adiposity and several obesity-related metabolic conditions were associated with thyroid cancer incidence. These findings provide insights into potential biological mechanisms linking obesity and thyroid cancer.<br />Funding: This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute and National Institute of Environmental Health Sciences (Z01-ES044005).<br />Competing Interests: All authors declare no conflict of interest.

Details

Language :
English
ISSN :
2667-193X
Volume :
23
Database :
MEDLINE
Journal :
Lancet regional health. Americas
Publication Type :
Academic Journal
Accession number :
37346380
Full Text :
https://doi.org/10.1016/j.lana.2023.100537